Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Sep;169(3):517-529.
doi: 10.1007/s11060-024-04705-3. Epub 2024 Aug 6.

Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study

Collaborators
Observational Study

Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study

INTERVAL-GB Collaborative et al. J Neurooncol. 2024 Sep.

Erratum in

Abstract

Purpose: Post-operative MRI is used to assess extent of resection, monitor treatment response and detect progression in high-grade glioma. However, compliance with accepted guidelines for follow-up MRI, and impact on management/outcomes is unclear.

Methods: Multi-center, retrospective observational cohort study of patients with confirmed WHO grade 4 glioma (August 2018-February 2019) receiving oncological treatment.

Primary objective: investigate follow-up MRI surveillance practice and compliance with recommendations from NICE (Post-operative scan < 72h, MRI every 3-6 months) and EANO (Post-operative scan < 48h, MRI every 3 months).

Results: There were 754 patients from 26 neuro-oncology centers with a median age of 63 years (IQR 54-70), yielding 10,100 (median, 12.5/person, IQR 5.2-19.4) person-months of follow-up. Of patients receiving debulking surgery, most patients had post-operative MRI within 72 h of surgery (78.0%, N = 407/522), and within 48 h of surgery (64.2%, N = 335/522). The median number of subsequent follow-up MRI scans was 1 (IQR 0-4). Compliance with NICE and EANO recommendations for follow-up MRI was 52.8% (N = 398/754) and 24.9% (N = 188/754), respectively. On multivariable Cox regression analysis, increased time spent in recommended follow-up according to NICE guidelines was associated with longer OS (HR 0.56, 95% CI 0.46-0.66, P < 0.001), but not PFS (HR 0.93, 95% CI 0.79-1.10, P = 0.349). Increased time spent in recommended follow-up according to EANO guidelines was associated with longer OS (HR 0.54, 95% CI 0.45-0.63, P < 0.001) but not PFS (HR 0.99, 95% CI 0.84-1.16, P = 0.874).

Conclusion: Regular surveillance follow-up for glioblastoma is associated with longer OS. Prospective trials are needed to determine whether regular or symptom-directed MRI influences outcomes.

Keywords: Glioblastoma; MRI; Neuro-oncology; Neuroimaging.

PubMed Disclaimer

Conflict of interest statement

All authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Distribution of MRI scan time following surgery stratified by extent of resection. Each dot represents an MRI scan and each row of dots represents a patient. GTR = gross total resection; STR = subtotal resection
Fig. 2
Fig. 2
Differences in interval imaging compliance stratified by extent of resection groups, Stupp protocol completion, and WHO performance status (PS). Fully compliant = a group that had every follow-up scan within the recommended time period; Inbetween = a group that had mixed periods of compliance with imaging, and mixed periods of non-compliance during follow-up; Never compliant = a group that had no imaging carried out within the recommended timeframe. STUPP protocol = full completion of STUPP protocol (adjuvant radiotherapy + concomitant and adjuvant chemotherapy); Other STUPP = Any other treatment (partial completion, no treatment)
Fig. 3
Fig. 3
Kaplan–Meier estimates of A) OS stratified by NICE imaging compliance (Full, Inbetween, Never), B) OS stratified by first progression detected by scheduled vs unscheduled MRI

References

    1. Ostrom QT et al (2020) CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–2017. Neuro Oncol 22(12 Suppl 2):iv1–iv96 - PMC - PubMed
    1. Brodbelt A et al (2015) Glioblastoma in England: 2007–2011. Eur J Cancer 51(4):533–542 - PubMed
    1. Stupp R et al (2005) Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med 352(10):987–996 - PubMed
    1. Delgado-López PD, Corrales-García EM (2016) Survival in glioblastoma: a review on the impact of treatment modalities. Clin Transl Oncol 18(11):1062–1071 - PubMed
    1. Weller M et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18(3):170–186 - PMC - PubMed

Publication types